July 3, 2018 | Abe Rosenberg
As director of City of Hope's Division of Mathematical Oncology, Russell Rockne, Ph.D., spends his days building mathematical models to help us better understand how cancer works.
Benjamin Djulbegovic, M.D., Ph.D., joins the Department of Supportive Care Medicine
June 8, 2018 | City of Hope
Benjamin Djulbegovic, M.D., Ph.D. is a professor and director of research in the Department of Supportive Care Medicine.
Stephen Forman, M.D., Inducted into AAP
May 30, 2018 | Michael Easterling
Stephen J. Forman, M.D., the Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation, has been inducted as a member of the Association of American Physicians.
Larry Kwak, M.D., Ph.D., Receives Grant for Promising Lymphoma Work
January 12, 2018 | Letisia Marquez
Larry Kwak, M.D., Ph.D., received a grant to support his work with mantle cell lymphoma from the Leukemia & Lymphoma Society, the world’s largest voluntary health organization dedicated to fighting blood cancer.
Geriatric assessment guides treatment strategy for older adults with cancer
December 1, 2017 | City of Hope
Researchers developed a self-administered geriatric assessment to identify areas of vulnerability and guide interventions for older adults with cancer.
Renowned Cancer Researcher Named President of City of Hope National Medical Center and Physician-in-Chief of City of Hope
November 28, 2017 | City of Hope
Michael A. Caligiuri, M.D., a world-renowned cancer researcher, has been named president of City of Hope National Medical Center and physician-in-chief of City of Hope.
City of Hope’s Ravi Salgia, M.D., Ph.D., honored by the IACA
June 2, 2017 | Letisia Marquez
City of Hope’s Ravi Salgia, M.D., Ph.D., whose accomplishments as a medical oncologist and researcher have helped shape modern cancer medicine, was celebrated at ASCO by the Indo-American Cancer Association (IACA) for his contributions to the field.
Translational researcher Larry Kwak explores lymphoma therapy's frontier
May 30, 2015 | City of Hope Staff
Lymphoma expert Larry Kwak has plans to improve the vaccine-based immunotherapy for which he is known. CAR T cells hold promise.